CN1074282C - Burn and scald ointment - Google Patents
Burn and scald ointmentInfo
- Publication number
- CN1074282C CN1074282C CN96119568A CN96119568A CN1074282C CN 1074282 C CN1074282 C CN 1074282C CN 96119568 A CN96119568 A CN 96119568A CN 96119568 A CN96119568 A CN 96119568A CN 1074282 C CN1074282 C CN 1074282C
- Authority
- CN
- China
- Prior art keywords
- medicine
- scalds
- burns
- ointment
- elasticity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to medicine for treating burns, scalds and injuries, namely ointment for burns and scalds. The ointment has the medicine components of the following proportion by weight: 10 to 50g of astragalus root, 10 to 50g of sanguisorba root, 10 to 50g of scorpion, 10 to 50g of myrrh, 10 to 50g of dahurian angelica root, 10 to 50g of borneol, 10 to 50g of antibiotics and 10 to 500g of adhesive. The medicine prepared by the proposal of the medicine has the functions of rapid inflammation elimination, pain alleviation, hemostasis, blood circulation promotion, rotted tissue removal and muscle regeneration. By a trial, the medicine of the medicine can be used by smearing for curing patients with general burns and scalds below the third degree for only 15 days or so. In addition, no scar remains, and less pigmentation exists. The elasticity and the mobility of skins are the same as the elasticity and the mobility of original skins. The medicine is the new generation of recovery therapeutic medicine for curing burns, scalds and injuries.
Description
The present invention relates to a kind of ointment that burn and scald injures wound that is used for the treatment of.
Before the present invention proposed, the up-to-date therapy that is used for the burn and scald treatment was a wet exposing therapy, and the medicine that is adopted is the unguentum of forming with Chinese medicine.Name is called MEIBAO.During use, ointment is applied on the skin, exposes then, approximately could fully recover through about 20 days time.Serious symptom burn and scald patient is then also needed skin-grafting, and this Scald Ointment therapeutic effect is better, but analgesic effect is unsatisfactory.So, the monobasic burn-scald medicine of renewal of needs development pain relieving and dephlogistication and promoting nuscle growth.
The objective of the invention is to develop a kind of double pain relieving, antibiotic, dephlogistication and promoting nuscle growth and do not stay the medicine of pigmentation and cicatrix.
The scheme that realizes the object of the invention is to adopt Chinese medicine ingredients and biochemical antibacterial compound, and be cream drug through mixing with adhesive.
Adopt the made medicine of the present invention program, by numerical example burn and scald patient's treatment in various degree, its cure rate reaches 100%.Following burn and scald patient uses to the III degree, simultaneously wrapping.The effect that can produce pain relieving, antiinflammatory immediately, stop blooding, invigorate blood circulation, through changing dressings several times, the big time about about 15 days both can return to original skin level.Thereby, the made medicine of the present invention program to burn and scald injure traumatic patient to resume treatment effect more satisfactory.
Specify below.
Composition and prescription:
The Radix Astragali 10~50g Radix Sanguisorbae 10~50g Squama Manis 10~50g
Myrrha 10~50g Radix Angelicae Dahuricae 10~50g Borneolum Syntheticum 10~50g
Antibiotics 10~50g binding agent 50~100g.
With above-mentioned Chinese medicine grind into powder, then with after antibacterial mixes, through with the binding agent mixed grinding evenly packing become the finished product unguentum.
The medicine that the present invention program is made, function cures mainly: pain relieving, antiinflammatory, recover the various types of cells prototype rapidly, each structure organization is constantly regenerated, the evacuation of pus granulation promoting.Tubercule bacillus there is powerful bacteriostasis, to gram negative bacilli and escherichia coli.Bacillus pestis, Brucella, bordetella pertussis, hemophilus influenza, streptococcus pneumoniae, bacillus pyocyaneus and most gram negative bacilli all have inhibitory action.
Medicine of the present invention is in sterilization, the antiphlogistic while, anticoagulant process effectively, but while activator protein enzyme and cellulase, promote damaged tissues metabolism and new histiocytic formation, thereby, promptly make the continuous hypertrophy of damaged cell vigor, until making skin reach original shape and elasticity.Because the growth of new cell is rapid, blood circulation is unimpeded, and the hemochromatosis probability is low, thereby, after skin recovers, there is not pigmentation substantially.Thereby, through patient's skin recovery effects the best of cured substance of the present invention.Both do not had the formation of pigmentation and cicatrix, and can recover the elasticity of skin again, simultaneously, speed is fast, and good analgesic effect has and uses future widely.
Claims (1)
1. an ointment for burns and scalds is characterized in that by Radix Astragali 10-50g, Radix Sanguisorbae 10-50g, and Squama Manis 10-50g, Myrrha 10-50g, Radix Angelicae Dahuricae 10-50g, Borneolum Syntheticum 10-50g, antibiotics 10-50g, binding agent 50-100g, formulated.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96119568A CN1074282C (en) | 1996-11-18 | 1996-11-18 | Burn and scald ointment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96119568A CN1074282C (en) | 1996-11-18 | 1996-11-18 | Burn and scald ointment |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1153656A CN1153656A (en) | 1997-07-09 |
CN1074282C true CN1074282C (en) | 2001-11-07 |
Family
ID=5125817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96119568A Expired - Fee Related CN1074282C (en) | 1996-11-18 | 1996-11-18 | Burn and scald ointment |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1074282C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111407791A (en) * | 2020-03-16 | 2020-07-14 | 鄂州职业大学 | External traditional Chinese medicine care solution for promoting wound healing |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1110581A (en) * | 1994-04-21 | 1995-10-25 | 张树森 | External-use decoction with Chinese herbal medicines |
CN1122709A (en) * | 1994-11-11 | 1996-05-22 | 柴西进 | Medicinal powder "Shulingsan" and its prepn. containing sweet potato |
-
1996
- 1996-11-18 CN CN96119568A patent/CN1074282C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1110581A (en) * | 1994-04-21 | 1995-10-25 | 张树森 | External-use decoction with Chinese herbal medicines |
CN1122709A (en) * | 1994-11-11 | 1996-05-22 | 柴西进 | Medicinal powder "Shulingsan" and its prepn. containing sweet potato |
Also Published As
Publication number | Publication date |
---|---|
CN1153656A (en) | 1997-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1110307C (en) | Medicine for curing tinea unguium | |
CN101648007B (en) | Pharmaceutical composition for treating ulcus cruris and preparation method thereof | |
CN1327873C (en) | Chinese traditional medicine for curing bone fracture and process for preparing the same | |
CN101850092A (en) | Medicament for treating trauma and preparation method thereof | |
CN1055013C (en) | Method for prepn. of Chinese medicinal external application ointment for diminishing inflammation, stopping pain and setting fracture | |
CN101612278A (en) | The medicine for external use of treatment pyogenic type contaminated wounds | |
CN1074282C (en) | Burn and scald ointment | |
CN108652815A (en) | A kind of internet intelligent massage Orthopedic splint of the combination of Chinese tradiational and Western medicine | |
CN102283887A (en) | Ointment for treating burn | |
CN101254277A (en) | External application paste for curing empyrosis | |
CN1192925A (en) | Medicine for treatment of piles | |
CN112870311A (en) | Female private part antibacterial hydrogel and using method thereof | |
CN1204909C (en) | Ointment made of Chinese medicinal herbs for treating bedsore difficult to cure | |
CN101406579B (en) | Novel use of pinellia | |
CN1058189C (en) | External- and thermal-mounted trauma medicinal powder bag | |
CN108283670A (en) | A kind of pharmaceutical composition and preparation method thereof for treating burn and scald | |
CN1237426A (en) | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer | |
CN1236798C (en) | External medicine for treating bone tuberculosis | |
CN1170570C (en) | Detoxicating ointment for treating burn and scald and its preparing process | |
CN1071124C (en) | Pharmaceutical composition for treating bed sore and ulcerous wound surface | |
CN1267545A (en) | Medicine for injury pain and its preparation | |
CN1329028C (en) | Ointment for quick curing trauma of burn and scald | |
CN100387289C (en) | Canine oil ointment for curing burn and stopping pain | |
CN1059100C (en) | Ointment for subsidence of swelling and relieving pain | |
CN100371011C (en) | Chinese medicine fast-acting ointment for treating septicemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |